Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Shaner, A.
* Articles by Mintz, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Shaner, A.
* Articles by Mintz, J.
Related Collections
* Chronically Mentally Ill Patients
* Dual Diagnosis Patients
* Cocaine
Psychiatr Serv 49:684-690, May 1998
© 1998 American Psychiatric Association


Other Article

Sources of Diagnostic Uncertainty for Chronically Psychotic Cocaine Abusers

Andrew Shaner, M.D., Lisa J. Roberts, M.A., Thad A. Eckman, Ph.D., J. Meg Racenstein, M.A., Douglas E. Tucker, M.D., John W. Tsuang, M.D. and Jim Mintz, Ph.D.

OBJECTIVE: This study determined the sources and frequency of diagnostic uncertainty for patients with chronic psychosis and active cocaine abuse or dependence and assessed the usefulness of prospective follow-up in clarifying diagnosis. METHODS: A total of 165 male patients with chronic psychoses and cocaine abuse or dependence on inpatient units of a Veterans Affairs medical center were evaluated using the Structured Clinical Interview for DSM-III-R (SCID-R), urine tests, hospital records, and interviews with collateral sources. An algorithm allowing key SCID-R items and diagnostic criteria to be designated as provisionally met or uncertain was applied, resulting in a provisional diagnosis and a list of alternate diagnoses. The assessment was repeated 18 months later in an attempt to resolve diagnostic uncertainty. RESULTS: In 30 cases (18 percent), initial assessment produced a definitive diagnosis, including 21 cases of schizophrenia, six of schizoaffective disorder, and three of psychostimulant-induced psychotic disorder. In the other 135 cases, a definitive diagnosis could not be reached because of one or more sources of diagnostic uncertainty, including insufficient periods of abstinence (78 percent), poor memory (24 percent), and inconsistent reporting (20 percent). Reassessment at 18 months led to definitive diagnoses in 12 additional cases. CONCLUSIONS: It was frequently difficult to distinguish schizophrenia from chronic substance-induced psychoses. Rather than concluding prematurely that psychotic symptoms are, or are not, substance induced, clinicians should initiate treatment of both psychosis and the substance use disorder in uncertain cases. The persistence or resolution of psychosis during abstinence and additional history from the stabilized patient or collateral sources may clarify the diagnosis.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
A. P. Ho, J. W. Tsuang, R. P. Liberman, R. Wang, J. N. Wilkins, T. A. Eckman, and A. L. Shaner
Achieving Effective Treatment of Patients With Chronic Psychotic Illness and Comorbid Substance Dependence
Am J Psychiatry, November 1, 1999; 156(11): 1765 - 1770.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org